Posts with tag parallel trade

Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide guidance for parallel traders of medicines. Key points Opening a medicine’s packaging in order to comply with EU regulations in the import country can leave visible traces. Such traces are not themselves sufficient to justify the parallel trader replacing...